Limited efficacy of atezolizumab and bevacizumab for hepatocellular carcinoma previously treated with tyrosine kinase inhibitor

Authors

Keywords

Journal

Volume 41, Issue 9, Pages 2233-2234

Publisher

Wiley

Online

2021-07-21

DOI

10.1111/liv.15010

References

View 4 related references

Explore over 38,000 international journals covering a vast array of academic fields.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started